Investor Relations


Headquartered in the UK since 2011, Fast Track Pharma is a pharmaceutical business with strong international links that is combining innovation with rapid and cost effective early value realisation.

The clinical focus of Fast Track Pharma is in gender health and pain. The business model for revenue generation is to:

  1. Achieve regulatory approval for internationally sourced products and then market and distribute products in Europe.
  2. Establish new intellectual property to enhance the performance of existing, generic drugs in their approved indications for the treatment of gender health and pain. This new intellectual property will be licensed to pharmaceutical partners either on a global or territorially basis after completion of quickly executed proof of concept studies.

This section of the Website is currently under construction and further details will be available shortly. Should you have any questions about Fast Track Pharma or are considering investment then please contact us on